These data suggest that the STZ-induced diabetic condition interfered with the migration of CD8+ T cells into MC38 tumors, resulting in impaired effects of anti-PD-1 antibody treatment on tumor growth in our mouse model. Here, PDCD1 is linked to neoplasm.